MedTrace Logo

Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores

NCT01902303 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2016-04-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if a new drug treatment is effective to block the development of a cold sore lesion following Ultra Violet (UV) exposure.

Conditions

  • Oral Herpes Simplex

Interventions

DRUG

Matching Placebo

Sublingual micro dosing of placebo for 7 days

DRUG

BTL-TML-HSV

Sublingual micro dosing of BTL-TML-HSV for 7 days

Sponsors & Collaborators

  • Norwich Clinical Research Associates Ltd.

    collaborator OTHER

  • Hill Top Research

    collaborator INDUSTRY

  • Beech Tree Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • John McMichael, PhD · President, Beech Tree Labs, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-09-30
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01902303 on ClinicalTrials.gov